HROW
Harrow Health Inc
30.40$
-0.8%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 29.4% | 31.1% | 30.5% | 25.6% | 24.4% | 21.2% | 32.5% | 25.5% | 24.7% | 20.7% | 38.8% | 28.7% | 26.7% | |
| 70.6% | 68.9% | 69.5% | 74.4% | 75.6% | 78.8% | 67.5% | 74.5% | 75.3% | 79.3% | 61.2% | 71.3% | 73.3% | |
| 4.1% | 9.2% | 6.2% | 6.2% | 4.6% | 7.1% | 6.3% | 4.5% | 4.6% | 3.7% | 13.3% | 11.4% | 7.5% | |
| 61.4% | 72.1% | 83.3% | 65.0% | 68.3% | 52.1% | 84.7% | 52.1% | 50.1% | 48.6% | 97.8% | 75.4% | 63.8% | |
| 65.5% | 82.3% | 89.5% | 71.3% | 72.9% | 59.5% | 91.0% | 56.6% | 54.7% | 52.3% | 111.1% | 86.9% | 71.2% | |
| 5.1% | -13.4% | -20.0% | 3.1% | 2.7% | 19.3% | -23.5% | 17.9% | 20.6% | 27.0% | -50.0% | -15.6% | 2.1% | |
| 16.8% | 14.1% | 15.7% | 11.2% | 11.2% | 9.5% | 13.7% | 10.1% | 8.4% | 5.8% | 12.4% | 8.9% | 8.3% | |
| -8.3% | -26.6% | -39.2% | -11.9% | -8.5% | 9.4% | -37.2% | 7.8% | 1.4% | 11.7% | -62.4% | -24.4% | -12.1% | |
| 4.5% | -1.5% | 9.1% | 1.3% | 0.0% | -0.8% | – | – | – | 4.2% | 0.1% | – | – | |
| -12.8% | -25.2% | -39.2% | -13.2% | -8.6% | 10.1% | -37.2% | 7.8% | 1.4% | 7.4% | -62.4% | -24.4% | -13.5% | |
| 16.8% | -4.8% | -15.3% | 5.1% | 8.7% | 26.3% | -14.0% | 25.1% | 16.2% | 22.9% | -37.3% | -15.6% | 1.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.